Proteasomal inhibition prevents lung and skin fibrosis after injury in part by increasing the abundance and activity of PPARγ. Proteasomal inhibition may offer a novel therapeutic alternative in patients with dysregulated tissue repair and fibrosis.
Department of Medicine, Northwestern University, Chicago, Illinois 60611, USA.
Thorax. 2012 Feb;67(2):139-46
© Galenicom 1999-2013